In thyroid nodules, Gal-3 expression was demonstrated by immunohistochemistry (IHC) utilizing histologic or cytologic specimens; numerous studies investigated Gal-3 in thyroid malignancy either as a single marker or as a part of a molecular panel. Here, LGALS3 is linked to thyroid nodule.